美国科学60秒 SSS 2015-06-03（在线收听）

 This is Scientific American 60 Seconds Science, I’m Sandia Grabber, got a minute?

Reshimenasis is sometimes fetal disease marked by skin orcers favor and splling and liver problems, it currently affects about 12 million people mostly in the developing world with about 2 million new affection annually. It’s cause by a parasisd which is spread by sand flies, there’s not good vaccine against reshimenasis, but researchers show that maybe worth wild target not parasisd but it’s a fly host, they are report good results and non-human primates and journal science translational medicine. Vaccine usually tragger on muse system to against pathganit agent, if that agent should actually show up, the immune system can disarm, but in this case, scientists armed at carier the sand fly, when affected fly by its victim and injects by parasic and . So the researcher suggested monkeys to repeated by its orinion affected by flies then should by its victim flies, and monkeys been first by the union fact partly practiced, could a spouse. The researchers then determind one particular protein in a into immune system into action, vaccine based on that protein offers partial protection which that 7 of 10 monkeys that have been got developing smaller orsers and stronger immune response and on their unbax up here affected with the parasid. These protein can be generated and purified easily from ecola which means that its possible to get large quality of it to produce a potential future human vaccine to against ma, which makes the slive protection nothing to speed up.

Thanks for the minute for Scientific American 60 Seconds Science, I’m Sandia Grabber.